Clavel M, Catimel G
Centre Léon Bérard, Lyon, France.
Eur J Cancer. 1993;29A(4):598-604. doi: 10.1016/s0959-8049(05)80161-3.
Chemotherapy in patients with advanced breast cancer remains palliative. Although the majority of patients will experience an initial response or stabilisation of the disease, the survival is only modestly improved. The search for new drugs and more effective combinations must therefore continue. High-dose chemotherapy with or without autologous bone marrow transplant (ABMT) is an enthusiastic perspective of progress but the available data do not permit conclusions about the effectiveness of high-dose therapy compared with conventional treatment.
晚期乳腺癌患者的化疗仍属姑息性治疗。尽管大多数患者会出现疾病的初始缓解或病情稳定,但生存期仅略有改善。因此,必须继续寻找新药和更有效的联合治疗方案。采用或不采用自体骨髓移植(ABMT)的大剂量化疗是一种充满希望的进展前景,但现有数据无法就大剂量治疗与传统治疗的有效性得出结论。